178 related articles for article (PubMed ID: 38398485)
41. A Case of Primary Sjögren's Syndrome Presenting as Mass-Like Encephalitis, With Progression to Neuromyelitis Optica Spectrum Disorder.
Lee HJ; Chang SH; Kang EH; Lee YJ; Song YW; Ha YJ
Arch Rheumatol; 2017 Dec; 32(4):353-357. PubMed ID: 29901009
[TBL] [Abstract][Full Text] [Related]
42. Post COVID-19 vaccination neuromyelitis optica spectrum disorder: Case report & MRI findings.
Badrawi N; Kumar N; Albastaki U
Radiol Case Rep; 2021 Dec; 16(12):3864-3867. PubMed ID: 34659602
[TBL] [Abstract][Full Text] [Related]
43. Seronegative Neuromyelitis Optica Spectrum Disorder following Exposure to Hepatitis B Vaccination.
Heekin R; Gandhy C; Robertson D
Case Rep Neurol; 2015; 7(1):78-83. PubMed ID: 25969683
[TBL] [Abstract][Full Text] [Related]
44. [A case of neuromyelitis optica spectrum disorders associated with primary biliary cholangitis: a twelve year follow-up study].
Sakai T; Kondo M; Kawana Y; Inoue R
Rinsho Shinkeigaku; 2022 Mar; 62(3):190-197. PubMed ID: 35228461
[TBL] [Abstract][Full Text] [Related]
45. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
[TBL] [Abstract][Full Text] [Related]
46. General anaesthesia for caesarean section in a patient with neuromyelitis optica spectrum disorder (NMOSD).
Dusitkasem S; Subsoontorn P
Int J Surg Case Rep; 2019; 60():72-74. PubMed ID: 31207529
[TBL] [Abstract][Full Text] [Related]
47. Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.
Mealy MA; Mossburg SE; Kim SH; Messina S; Borisow N; Lopez-Gonzalez R; Ospina JP; Scheel M; Yeshokumar AK; Awad A; Leite MI; Arango JJ; Paul F; Palace J; Kim HJ; Levy M
Mult Scler Relat Disord; 2019 Feb; 28():64-68. PubMed ID: 30554040
[TBL] [Abstract][Full Text] [Related]
48. Clinical and Radiological Characteristics of Neuromyelitis Optica Spectrum Disorder: The Experience from Saudi Arabia.
Algahtani H; Shirah B; Ibrahim B; Malik YA; Makkawi S
Mult Scler Relat Disord; 2021 Jan; 47():102668. PubMed ID: 33307475
[TBL] [Abstract][Full Text] [Related]
49. Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review.
Ferilli MAN; Paparella R; Morandini I; Papetti L; Figà Talamanca L; Ruscitto C; Ursitti F; Moavero R; Sforza G; Tarantino S; Proietti Checchi M; Vigevano F; Valeriani M
Life (Basel); 2021 Dec; 12(1):. PubMed ID: 35054412
[TBL] [Abstract][Full Text] [Related]
50. Radiomics in multiple sclerosis and neuromyelitis optica spectrum disorder.
Liu Y; Dong D; Zhang L; Zang Y; Duan Y; Qiu X; Huang J; Dong H; Barkhof F; Hu C; Fang M; Tian J; Li K
Eur Radiol; 2019 Sep; 29(9):4670-4677. PubMed ID: 30770971
[TBL] [Abstract][Full Text] [Related]
51. Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
Motahharynia A; Naghavi S; Shaygannejad V; Adibi I
Mult Scler Relat Disord; 2022 Oct; 66():104035. PubMed ID: 35858498
[TBL] [Abstract][Full Text] [Related]
52. Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review.
Shahmohammadi S; Doosti R; Shahmohammadi A; Mohammadianinejad SE; Sahraian MA; Azimi AR; Harirchian MH; Asgari N; Naser Moghadasi A
Mult Scler Relat Disord; 2019 Jan; 27():350-363. PubMed ID: 30476871
[TBL] [Abstract][Full Text] [Related]
53. Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.
Stastna D; Menkyova I; Drahota J; Mazouchova A; Adamkova J; Ampapa R; Grunermelova M; Peterka M; Recmanova E; Rockova P; Rous M; Stetkarova I; Valis M; Vachova M; Woznicova I; Horakova D
Mult Scler Relat Disord; 2021 Sep; 54():103104. PubMed ID: 34216998
[TBL] [Abstract][Full Text] [Related]
54. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
55. Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders.
Yazdan Panah M; Vaheb S; Mokary Y; Afshari-Safavi A; Shaygannejad A; Ebrahimi N; Shaygannejad V; Mirmosayyeb O
Vaccine; 2024 Jun; ():. PubMed ID: 38886142
[TBL] [Abstract][Full Text] [Related]
56. Longitudinally Extensive Transverse Myelitis: A Retrospective Study Differentiating Neuromyelitis Optica Spectrum Disorder From Other Etiologies.
Paudel S; Nepal G; Guragain S; Shah S; Paudel BS; Ojha R; Rajbhandari R; Karn R; Gajurel BP; Paudel S
Cureus; 2021 Mar; 13(3):e13968. PubMed ID: 33884229
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of rituximab in the treatment of neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
Wang Y; Chang H; Zhang X; Yin L
Mult Scler Relat Disord; 2021 May; 50():102843. PubMed ID: 33609924
[TBL] [Abstract][Full Text] [Related]
58. Neuromyelitis Optica spectrum disorders in Argentina: A hospital-based study.
Villa AM; Manin A; Seimandi C; Finkelsteyn AM; Ramos G; Tenembaum S
Mult Scler Relat Disord; 2023 Nov; 79():105018. PubMed ID: 37806234
[TBL] [Abstract][Full Text] [Related]
59. Long-term outcome and prognosis in patients with neuromyelitis optica spectrum disorder from Serbia.
Drulovic J; Martinovic V; Basuroski ID; Mesaros S; Mader S; Weinshenker B; Pekmezovic T
Mult Scler Relat Disord; 2019 Nov; 36():101413. PubMed ID: 31586803
[TBL] [Abstract][Full Text] [Related]
60. Magnetic resonance imaging in neuromyelitis optica spectrum disorder.
Clarke L; Arnett S; Lilley K; Liao J; Bhuta S; Broadley SA
Clin Exp Immunol; 2021 Dec; 206(3):251-265. PubMed ID: 34080180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
